|
Market Closed -
NYSE
23:00:02 04/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 47.80 USD | +1.81% |
|
-1.04% | -49.87% |
| 09-04 | US companies face rise in cyber attacks | RE |
| 09-01 | Oncology firm Novocure says cyberattack exposed US patient records | RE |
| Market Cap | 69.27B 59.57B 56.03B 51.15B 95.66B 6,551B 95.97B 664B 257B 3,355B 260B 254B 10,687B | P/E 2026 * |
17.8x | P/E 2027 * | 18.8x |
|---|---|---|---|---|---|
| Enterprise Value | 77.99B 67.07B 63.08B 57.59B 108B 7,376B 108B 748B 289B 3,777B 293B 286B 12,031B | EV / Sales 2026 * |
3.65x | EV / Sales 2027 * | 3.35x |
| Free-Float |
82.47% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| BSX | Delayed | |
CBOE
| BSX | Real-time | |
|
Tradegate
| BSX | Real-time | |
|
Mexican S.E.
| BSX * | End-of-day quote | |
|
Boerse Muenchen
| BSX | Real-time | |
|
Wiener Boerse
| BSXC | End-of-day quote | |
|
Xetra
| BSX | Delayed | |
|
Borsa Italiana
| 1BSX | End-of-day quote | |
|
London S.E.
| 0HOY | Delayed | |
|
Börse Stuttgart
| BSX | Delayed | |
|
Deutsche Boerse AG
| BSX | Delayed | |
|
Swiss Exchange
| BSX | Delayed | |
|
Swiss Exchange
| BSX | Delayed | |
|
CBOE
| 0HOY | Real-time | |
|
CBOE
| Real-time |
Last Transcript : Boston Scientific Corporation
| 1 day | +1.81% | ||
| 1 week | -1.04% | ||
| Current month | -1.04% | ||
| 1 month | -3.06% | ||
| 3 months | -1.54% | ||
| 6 months | -33.01% | ||
| Current year | -49.87% |
| 1 week | 46.8 |  | 49.66 |
| 1 month | 46.09 | | 52.99 |
| Current year | 42.2 | | 100.9 |
| 1 year | 42.2 | | 109.5 |
| 3 years | 42.2 | | 109.5 |
| 5 years | 34.98 | | 109.5 |
| 10 years | 19.67 | | 109.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Mahoney
CEO | Chief Executive Officer | 61 | 01/11/2011 |
Jonathan Monson
DFI | Director of Finance/CFO | 52 | 30/06/2025 |
Kenneth Stein
CTO | Chief Tech/Sci/R&D Officer | - | 01/09/2009 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Mahoney
CHM | Chairman | 61 | 03/05/2016 |
Edward Ludwig
BRD | Director/Board Member | 74 | 01/03/2014 |
Ellen Zane
BRD | Director/Board Member | 74 | 15/04/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/25/26 A | Buy | Director | 2,040 | 0.0001% | ||
| 8/11/26 A | Other | Controller/Auditor | 2,930 | 0.0002% | ||
| 8/10/26 A | Other | Chief Financial Officer | 9,908 | 0.0007% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.81% | -1.04% | -55.42% | -11.30% | 69.27B | |
| -0.75% | -0.54% | +24.60% | +15.45% | 227B | |
| -1.60% | -2.76% | +3.72% | -18.54% | 146B | |
| -0.85% | -2.70% | -21.45% | +23.38% | 130B | |
| +0.13% | -0.94% | +11.07% | +18.15% | 51.82B | |
| -0.04% | -1.96% | -18.95% | -13.75% | 49.99B | |
| +0.59% | -1.76% | +17.17% | +29.76% | 42.53B | |
| -1.01% | -1.27% | +33.64% | +51.45% | 40.22B | |
| -1.55% | +2.15% | +120.58% | +37.37% | 32.95B | |
| -0.37% | -4.89% | -17.58% | +51.73% | 32.67B | |
| Average | -0.36% | -1.34% | +9.74% | +18.37% | 82.19B | |
| Weighted average by Cap. | -0.56% | -1.55% | +5.62% | +11.62% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 21.37B 18.37B 17.28B 15.78B 29.5B 2,021B 29.6B 205B 79.2B 1,035B 80.24B 78.48B 3,296B | 22.33B 19.2B 18.06B 16.49B 30.83B 2,112B 30.93B 214B 82.77B 1,081B 83.85B 82.01B 3,444B |
| Net income | 3.84B 3.3B 3.11B 2.83B 5.3B 363B 5.32B 36.82B 14.23B 186B 14.42B 14.1B 592B | 3.69B 3.17B 2.98B 2.72B 5.09B 349B 5.11B 35.35B 13.66B 179B 13.84B 13.54B 569B |
| Net Debt | 8.72B 7.5B 7.05B 6.44B 12.04B 824B 12.08B 83.6B 32.32B 422B 32.74B 32.02B 1,345B | 5.45B 4.69B 4.41B 4.03B 7.53B 516B 7.55B 52.28B 20.21B 264B 20.47B 20.03B 841B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/09/26 | $47.80 | +1.81% | 15,504,234 |
| 03/09/26 | $46.95 | -2.94% | 19,732,249 |
| 02/09/26 | $48.37 | +0.60% | 17,017,972 |
| 01/09/26 | $48.08 | -0.46% | 12,004,264 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BSX Stock
Select your edition
All financial news and data tailored to specific country editions
